Rivaroxaban CAS 366789-02-8 Ubunyulu > 99.5% (HPLC) Factory API High Quality

Inkcazelo emfutshane:

Igama leKhemikhali: Rivaroxaban

CAS: 366789-02-8

Ubunyulu: >99.5% (HPLC)

Imbonakalo: Umgubo oMhlophe okanye ophantse wamhlophe

Umgangatho ophezulu we-API, iMveliso yoRhwebo

E-Mail: alvin@ruifuchem.com

Thumela i-imeyile kuthi

Iinkcukacha zeMveliso

Iimveliso ezinxulumeneyo

Iithegi zeMveliso

Inkcazo:

Ubonelelo loMvelisi iRivaroxaban eNxulumeneyo nabaPhakathi:
(S)-(+)-Glycidyl Phthalimide CAS 161596-47-0
4-(4-Aminophenyl)morpholin-3-enye CAS 438056-69-0
Rivaroxaban Intermediate CAS 446292-07-5
I-5-Chlorothiophene-2-Carboxylic Acid CAS 24065-33-6
5-Chlorothiophene-2-Carbonyl Chloride CAS 42518-98-9
Rivaroxaban API CAS 366789-02-8

Iipropati zeMichiza:

Igama leMchiza	Rivaroxaban
Izithethantonye	(S)-Rivaroxaban;(S) -5-Chloro-N-((2-oxo-3-(4-(3-oxomorpholino)phenyl)-oxazolidin-5-yl)methyl)thiophene-2-carbox;I-BAY 59-7939
Inombolo yeCAS	366789-02-8
Ubume beStokhwe	Kwi-Stock, iMveliso yoMveliso ukuya kwiiToni
Ifomula yeemolekyuli	I-C19H18ClN3O5S
Ubunzima beMolekyuli	435.88
Uphawu	Ruifu Chemical

Iinkcukacha:

Into	Iinkcukacha
Imbonakalo	Umgubo oMhlophe okanye ophantse wamhlophe
Isazisi A	I-infrared absorption ye-Rivaroxaban ihambelana nemigangatho yereferensi
Isazisi B	Ixesha lokugcinwa kwencopho ephambili yesisombululo sesampulu ihambelana nesisombululo sokufaneleka kwenkqubo, njengoko ifunyenwe kwi-enantiomeric purity.
Ucoceko lwe-Enantiomeric	I-RVX RC01: ≤0.15%
Ukufuma (KF)	≤0.50%
Uthuthu lweSulfate	≤0.10%
Iintsimbi ezinzima	≤20ppm
I-Acetic Acid	≤5000ppm
Izinto eziyeleleneyo (HPLC)
I-RVX RC02	≤0.15%
I-RVX RC03	≤0.15%
I-RVX RC04	≤0.15%
RVX RC05	≤0.15%
I-RVX RC06	≤0.15%
I-RVX RC07	≤0.15%
I-RVX RC08	≤0.15%
Nakuphi na Okunye Ukungacoceki komntu	≤0.10%
Ukungcola ngokupheleleyo	<0.50%
Intsalela yezinyibilikisi (GC)
I-Ethanol	≤5000ppm
Toluene	≤890ppm
I-Triethylamine	≤320ppm
Ubunyulu / Indlela yokuHlalutya	>99.5% (HPLC) (kwisiseko se-anhydrous)
Umgangatho woVavanyo	Umgangatho woShishino
Ukusetyenziswa	API;Iziyobisi zeAntithrombotic;I-FXa Inhibitor

Ukupakishwa kunye noGcino:

Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, 25kg/Igubu lekhadibhodi, okanye ngokwemfuno yomthengi.

Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ukukhanya kunye nokufuma.

Izinto eziluncedo:

FAQ:

Isicelo:

Rivaroxaban(I-CAS:366789-02-8) (Xarelto, Bayer) yi-anticoagulant yomlomo.Yinto yomlomo esebenzayo ngokuthe ngqo xa inhibitor.I-Rivaroxaban iboniswa 'unyango lwe-vein thrombosis enzulu kunye ne-pulmonary embolism, kunye nokukhusela i-thrombosis ye-deep vein thrombosis kunye ne-pulmonary embolism kubantu abadala'.Ngonyango lokuqala lwe-acute pulmonary embolism, i-dosage ephakanyisiweyo ye-rivaroxaban yi-15 mg kabini imihla ngemihla ngeentsuku zokuqala ze-21 ezilandelwa ngu-20 mg kanye ngosuku ngokuqhubekayo unyango kunye nokuthintela i-thromboembolism ye-venous ephindaphindiweyo.I-Non-Valvular Atrial Fibrillation (i-NVAF) yokukhusela i-stroke kunye ne-systemic embolism.Unyango lwe-VTE olubukhali kunye nokuthintela i-VTE ephindaphindiweyo [ye-deep vein thrombosis (DVT) kunye ne-pulmonary embolism (PE)].Ukuthintelwa kweziganeko ze-venous thromboembolic (VTE) kwi-elective total hip okanye utyando lokutshintshwa kwamadolo (THR, TKR).